Breast Cancer Specialist Presents Positive Results for Triple-Negative Breast Cancer Presurgery Chemotherapy Benefits
Dr. William Sikov, associate chief of clinical research with the Program in Women's Oncology at Women & Infants and associate professor of medicine at The Warren Alpert Medical School of Brown University, found that adding either carboplatin or bevacizumab to standard chemotherapy treatment before surgery helped triple-negative breast cancer patients.
WIH Awarded Coveted 2014 Leapfrog Top Hospital Distinction
For the first time, The Leapfrog Group
has named Women & Infants Hospital to its annual list of Top Hospitals. An elite
distinction awarded to hospitals nationwide for demonstrating excellence
in hospital safety and quality through the Leapfrog Hospital Survey,
the Leapfrog Hospital award is given to less than seven percent of all
Johnston Nurse Recognized at Women & Infants Hospital
A second Murray Family Infusion Center nurse was honored with the DAISY Award this month. Ivone Burgess is best known by her patients for spoiling them with an ability to make them forget they are even receiving treatment at all. Ivone is also greatly appreciated for her enthusiasm in her working relationship with all of her peers.
Dr. Glenn Palomaki Contributes to Debate on Breast Cancer Screening
What are the risks and benefits of screening for BRCA1 and BRCA2 mutations in the general adult population? Dr. Glenn Palomaki has published an invited commentary in Genetics in Medicine on this issue.
Raymond O. Powrie, MD, FRCP(C), FACP, underscored his belief in the “team approach” by drawing together a multidisciplinary group to edit an international textbook on medical disorders in obstetric patients.
Meet five patients who are being cared for at Women & Infants Hospital, women and newborns whose treatment has been enhanced by the incredible research, compassion, and commitment to excellence that is Women & Infants. » Patient Stories